NOVOPHARMA PLUS

HISTORY OF THE COMPANY

For centuries, medicine was one of the major cultural values of peoples of Central Asia. The whole world knows the great scientist, pharmacist, physician Abu Ali Ibn Sina, who built the medicine to class of art. His multivolume "The Canon of Medicine" was one of the first editions, which was printed in Europe after the invention of the printing press. In the Canon it was given the description of more than 800 drugs of plant, animal and mineral origin, many of which are still used in modern medicine. Our company, in its period of development, set a goal to continue traditions of our great ancestors and to bring the art of preparing medicines to perfection.

2001-2004

idea and developement

Development of general concept of the project, preparation of infrastructure and production facilities, buying and installation of modern production equipment, creation of testing laboratory.
Result – the birth of modern enterprise for production of finished drugs.

years of great changes

Certificate for Quality Management System (Certificate Registration №UZ/29/0296359877 on June 13, 2013) suggests that the introduction and used by the Quality Management System in the JV LLC «NOVOPHARMA PLUS» meet the requirements of ISO 9001: 2008 with regard to the scope: Design and Development, manufacturing and Distribution of medical products for Human Use. An audit conducted by an independent certification body LLC «International Certificate System Group» - the Tashkent branch of the ACS Registrars Ltd (UK). The certificate is valid until June 12, 2016.

GMP Certificate

Demonstration of compliance with GMP is the Certificate in Quality Management System JV «NOVOPHARMA PLUS», which is to certify that the introduction and used by the Quality Management System meets the requirements of Good Manufacturing Practice (GMP). Through an audit by an authorized certification body LLC «International Certificate System Group», documented in the report was received confirmation of compliance of the Quality Management System requirements of the EU Commission 2003/94/ES (GMP - Guide, Part 1). Scope: Design and Development, manufacturing and Distribution of medical products for human use.

For more information:
http://www.novopharma.uz/index_en.html